Iniciar sesión Regístrese gratis

AMAG Pharmaceuticals Propiedad de la dirección

¿Qué es el Propiedad de la dirección de AMAG Pharmaceuticals?

El Propiedad de la dirección de AMAG Pharmaceuticals, Inc. es 1.75%

¿Cuál es la definición de Propiedad de la dirección?



La propiedad de personas con información privilegiada se calcula como el número total de acciones propiedad de personas con información privilegiada (accionistas que poseen más del 5% de la corporación o un funcionario o director de la compañía) dividido por el total de Acciones en circulación.

A high value of insider ownership means that those working for the company have a large stake in the success of the company. This is sometimes seen as a sign that those running the company will work hard to ensure its success or believe the company's stock price will rise.

A change in insider ownership may come from exercise of option, stock grant and buying or selling of company shares. A purchase of company share signifies a confidence in the company's future performance by people who know the company best. Therefore, Net Insider buying is also an important indicator for investors.

Propiedad de la dirección de compañías en Sector Health Care en NASDAQ en comparadas con AMAG Pharmaceuticals

¿Qué hace AMAG Pharmaceuticals?

AMAG Pharmaceuticals, Inc. is a biopharmaceutical company. It focuses on the manufacture, development, and commercialization of a therapeutic iron compound to treat iron deficiency anemia. The firm focuses on the development and commercialization of Feraheme injection for intravenous use to treat iron deficiency anemia. It manufactures, develops, and commercializes products derived from its proprietary technology for use in treating human diseases. Its products include Intrarosa, Vyleesi, Makena, CBR, Feraheme, and MuGard. The company was founded on November 9, 1981 and is headquartered in Waltham, MA.

Empresas con propiedad de la dirección similar a AMAG Pharmaceuticals